8 Insys Docs Tallied $28M In Medicare Costs, Jury Hears
By Chris Villani · March 29, 2019, 4:31 PM EDT
Eight top prescribers of Insys Therapeutics Inc.'s opioid spray accounted for more than $28 million in Medicare bills for the drug, an FBI witness testified Friday as federal prosecutors tried to...
To view the full article, register now.